Tag: CDK4/6 inhibitor

Preoperative bilateral breast imaging may reduce contralateral cancer recurrence

Ribociclib in addition to letrozole increases overall survival compared to letrozole alone

byKassandra McFarlaneand1 others

March 21, 2022

1. Overall survival was longer in the group receiving ribociclib with letrozole as compared with the placebo group 2. Severe ...

#VisualAbstract: Fulvestrant plus cyclin-dependent kinase 4/6 inhibitors improves survival in HR⁺, HER2- metastatic breast cancer

byTeddy Guo

February 15, 2022

Click to read this study in Lancet Oncology.

#VisualAbstract: Addition of palbociclib to adjuvant endocrine therapy does not improve survival in patients with HR⁺, HER2- breast cancer

byTeddy Guo

February 17, 2021

Click to read the study in The Lancet Oncology.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result